跨导管大动脉置换后心脏导电的变化背后的机制
Jonathan W Waks1, Marie-France Poulin1, John-Ross D Clarke1,2
1Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
JAMA cardiology
|December 10, 2025
概括
过导管大动脉置换 (TAVR) 可以导致心脏阻塞. 这项研究发现,手术内和延迟心脏阻塞有不同的原因和预测因素,有助于更好地管理患者.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 干预心脏病学 干预心脏病学
背景情况:
- 过导管大动脉置换 (TAVR) 是对大动脉狭窄的常见治疗方法.
- 需要心脏起器植入的心脏阻塞使至少10%的TAVR手术复杂化.
- 了解TAVR后心脏阻塞的机制对于改善患者的治疗结果至关重要.
研究的目的:
- 为了研究TAVR后心脏阻塞背后的机制.
- 为了确定TAVR后手术内和延迟心脏阻塞的预测因子.
- 要区分AV节点和下节点阻断机制.
主要方法:
- 一项前性队列研究,包括409名未使用心脏起器接受TAVR的患者.
- 连续心电图 (ECG) 和他的捆绑记录在TAVR期间由电生理学家.
- 电生理学研究在TAVR前和之后进行,随访1年.
主要成果:
- 9.7%的患者患有心脏阻塞,需要植入心脏起器.
- 程序内阻断是由先前存在的右束分支阻断 (RBBB) 预测的.
- 延迟心脏阻塞预测因素包括长时间的His-ventricular间隔,PR间隔和AV Wenckebach周期长度.
结论:
- 在TAVR期间和之后心脏阻塞的机制显著不同.
- 在TAVR后,AV节点和下节点阻塞都会导致心脏阻塞.
- 识别特定的预测因素可以改善与TAVR相关的心脏阻塞的风险分层和管理.
相关概念视频
Aortic Regurgitation I: Introduction
423
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
423
Aortic Regurgitation III: Medical Management
359
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
359
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
361
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
361
Mitral Valve Prolapse I: Introduction
337
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
337
Conduction System of the Heart
12.3K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.3K


